Sudeep Pharma Ltd.
SUDEEPPHRM.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$118.63B
Close$
Share Statistics
| Market cap | $118.63 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $1.50 (0.14%) |
| Earnings per Share | $- |
| Beta | 1.28 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.04
Average shareholder expectationRevenue Estimate
$1.60 B
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$4.20
Average shareholder expectationRevenue Estimate
$1.78 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sudeep Pharma Ltd.
480 employees
CEO: Sujit Jaysukh Bhayani Established in 1989 and headquartered in Vadodara, India, Sudeep Pharma Limited specializes in the manufacturing and distribution of excipients and unique ingredients. The company serves the pharmaceutical, food, and nutrition sectors, w...